Filtros de búsqueda

Lista de obras de Louis B Nabors

1p/19q chromosome deletions in metastatic oligodendroglioma.

artículo científico publicado en 2006

A novel technique to quantify glioma tumor invasion using serial microscopy sections.

artículo científico publicado en 2006

A phase 1 trial of ABT-510 concurrent with standard chemoradiation for patients with newly diagnosed glioblastoma.

artículo científico publicado en 2010

A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses.

artículo científico publicado en 2014

A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting.

artículo científico publicado en 2004

A phase I/II trial of pazopanib in combination with lapatinib in adult patients with relapsed malignant glioma.

artículo científico

A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306)

artículo científico publicado en 2012

Activation of the receptor tyrosine kinase AXL regulates the immune microenvironment in glioblastoma.

artículo científico publicado en 2018

Analgesic use and the risk of primary adult brain tumor

artículo científico publicado en 2016

Analysis of the 5' end of the mouse Elavl1 (mHuA) gene reveals a transcriptional regulatory element and evidence for conserved genomic organization.

artículo científico publicado en 2000

Anthropometric factors in relation to risk of glioma

artículo científico publicado en 2013

Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: quality and analysis results of a phase I trial.

artículo científico publicado en 2004

Brain tumor risk according to germ-line variation in the MLLT10 locus

artículo científico publicado en 2014

Cancer susceptibility variants and the risk of adult glioma in a US case-control study.

artículo científico publicado en 2011

Capacity of patients with brain metastases to make treatment decisions

artículo científico publicado en 2015

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

artículo científico publicado en 2014

Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome

artículo científico publicado en 2016

Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme

scientific article published on 01 August 2008

Circadian pathway genes in relation to glioma risk and outcome

scientific article published on 18 October 2013

Cognition in patients with newly diagnosed brain metastasis: profiles and implications.

artículo científico publicado en 2014

Cognitive Predictors of Reasoning through Treatment Decisions in Patients with Newly Diagnosed Brain Metastases.

artículo científico publicado en 2015

Complications from pharmacotherapy

artículo científico publicado en 2016

Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma

artículo científico publicado en 2016

Diagnosing growth in low-grade gliomas with and without longitudinal volume measurements: A retrospective observational study.

artículo científico publicado en 2019

Distress and quality of life in primary high-grade brain tumor patients.

artículo científico publicado en 2009

Early life exposures and the risk of adult glioma

artículo científico publicado en 2013

Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study.

artículo científico publicado en 2017

Evaluation of the Safety and Benefit of Phase I Oncology Trials for Patients With Primary CNS Tumors.

artículo científico publicado en 2015

Expression of PRMT5 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth in vitro.

artículo científico publicado en 2014

Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy

scientific article published on 16 September 2020

Growth factor dependent regulation of centrosome function and genomic instability by HuR.

artículo científico publicado en 2015

Hu Antigen R (HuR) multimerization contributes to glioma disease progression.

artículo científico

HuR, a novel target of anti-Hu antibodies, is expressed in non-neural tissues

artículo científico publicado en 1998

Increased expression of thymidylate synthetase (TS), ubiquitin specific protease 10 (USP10) and survivin is associated with poor survival in glioblastoma multiforme (GBM).

artículo científico publicado en 2006

Ipilimumab-induced encephalopathy with a reversible splenial lesion.

artículo científico publicado en 2015

Isolated central nervous system posttransplant lymphoproliferative disorder treated with high-dose intravenous methotrexate.

artículo científico publicado en 2009

Lyn kinase activity is the predominant cellular SRC kinase activity in glioblastoma tumor cells.

artículo científico publicado en 2005

Magnetic resonance cisternography in the diagnosis of delayed iatrogenic cerebrospinal fistula: a case report

scientific article published on 01 October 1997

Medical decision-making capacity in patients with malignant glioma

artículo científico publicado en 2009

Methylmercury exposure, genetic variation in metabolic enzymes, and the risk of glioma

artículo científico publicado en 2019

Mutant tristetraprolin: a potent inhibitor of malignant glioma cell growth.

artículo científico publicado en 2013

NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme.

artículo científico publicado en 2013

NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017.

artículo científico publicado en 2017

Older age at the completion of linear growth is associated with an increased risk of adult glioma.

artículo científico publicado en 2017

Patterns of failure for glioblastoma multiforme following concurrent radiation and temozolomide.

artículo científico publicado en 2011

Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: final report of NABTT 97-11.

artículo científico publicado en 2004

Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma.

artículo científico publicado en 2007

Phase I and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomas

artículo científico publicado en 2011

Phase I and pharmacokinetic study of karenitecin in patients with recurrent malignant gliomas.

artículo científico publicado en 2008

Phase I study of iniparib concurrent with monthly or continuous temozolomide dosing schedules in patients with newly diagnosed malignant gliomas.

artículo científico publicado en 2015

Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177.

artículo científico publicado en 2006

Phase I trial of sorafenib in patients with recurrent or progressive malignant glioma.

artículo científico publicado en 2011

Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma

artículo científico publicado en 2018

Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma

artículo científico publicado en 2013

Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM

artículo científico publicado en 2008

Phosphoregulation of the RNA-binding protein Hu antigen R (HuR) by Cdk5 affects centrosome function.

artículo científico publicado en 2012

Pilot Study to Explore the Accuracy of Current Prediction Equations in Assessing Energy Needs of Patients with Newly Diagnosed Glioblastoma Multiforme.

artículo científico publicado en 2016

Prediagnostic body weight and survival in high grade glioma.

artículo científico publicado en 2013

Primary Sellar Rhabdomyosarcoma Arising in Association With a Pituitary Adenoma

artículo científico publicado en 2016

Primary central nervous system angiosarcoma: two case reports

artículo científico

Prolonged treatment with bevacizumab is associated with brain atrophy: a pilot study in patients with high-grade gliomas

artículo científico publicado en 2015

Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials

artículo científico publicado en 2018

Quantitative immunocytochemistry using an image analyzer. II. Concentration standards for transmitter immunocytochemistry

artículo científico publicado en 1988

RareTP53genetic variant associated with glioma risk and outcome ⬇️

artículo científico publicado el 15 de junio de 2012

Reproductive factors and risk of primary brain tumors in women

artículo científico publicado en 2014

SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma

artículo científico publicado en 2015

SSBP2 variants are associated with survival in glioblastoma patients

scientific journal article

SWI/SNF gene variants and glioma risk and outcome.

artículo científico publicado en 2012

Sex hormone-dependent attenuation of EAE in a transgenic mouse with astrocytic expression of the RNA regulator HuR ⬇️

artículo científico publicado el 22 de marzo de 2012

Survival analysis in patients with newly diagnosed primary glioblastoma multiforme using pre- and post-treatment peritumoral perfusion imaging parameters.

artículo científico publicado en 2014

Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.

artículo científico publicado en 2010

The ELAV RNA-stability factor HuR binds the 5'-untranslated region of the human IGF-IR transcript and differentially represses cap-dependent and IRES-mediated translation

artículo científico publicado en 2005

The RNA-binding protein HuR promotes glioma growth and treatment resistance.

artículo científico publicado en 2011

The role of Src family kinases in growth and migration of glioma stem cells.

artículo científico publicado en 2014

The use of cannabidiol for seizure management in patients with brain tumor-related epilepsy

artículo científico publicado en 2017

Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas

artículo científico publicado en 2017

Toenail iron, genetic determinants of iron status, and the risk of glioma

artículo científico publicado en 2013

Treatment of primary CNS lymphoma with high-dose methotrexate in immunocompetent pediatric patients

scientific article published on 01 December 2010

Treatment of relapsed central nervous system lymphoma with high-dose methotrexate

artículo científico publicado en 2004

Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study

artículo científico publicado en 2015

When less is better: care of the elderly with glioblastoma.

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda